363 related articles for article (PubMed ID: 27686653)
1. Available Evidence on Leber Congenital Amaurosis and Gene Therapy.
Alkharashi M; Fulton AB
Semin Ophthalmol; 2017; 32(1):14-21. PubMed ID: 27686653
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for RPE65-related retinal disease.
Miraldi Utz V; Coussa RG; Antaki F; Traboulsi EI
Ophthalmic Genet; 2018 Dec; 39(6):671-677. PubMed ID: 30335549
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for Leber congenital amaurosis: advances and future directions.
Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA
Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial].
Chacón-Camacho ÓF; Zenteno JC
Gac Med Mex; 2017; 153(2):276-278. PubMed ID: 28474714
[TBL] [Abstract][Full Text] [Related]
5. A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy.
Glen WB; Peterseim MMW; Badilla R; Znoyko I; Bourg A; Wilson R; Hardiman G; Wolff D; Martinez J
Ophthalmic Genet; 2019 Apr; 40(2):110-117. PubMed ID: 30870047
[TBL] [Abstract][Full Text] [Related]
6. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635
[TBL] [Abstract][Full Text] [Related]
7. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
Stein L; Roy K; Lei L; Kaushal S
Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
Li S; Samardzija M; Yang Z; Grimm C; Jin M
J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
[TBL] [Abstract][Full Text] [Related]
9. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
Kondkar AA; Abu-Amero KK
Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339
[TBL] [Abstract][Full Text] [Related]
10. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.
Kumaran N; Moore AT; Weleber RG; Michaelides M
Br J Ophthalmol; 2017 Sep; 101(9):1147-1154. PubMed ID: 28689169
[TBL] [Abstract][Full Text] [Related]
11. Dog models for blinding inherited retinal dystrophies.
Petersen-Jones SM; Komáromy AM
Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity Reclasssification of
Motta FL; Martin RP; Porto FBO; Wohler ES; Resende RG; Gomes CP; Pesquero JB; Sallum JMF
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31878136
[TBL] [Abstract][Full Text] [Related]
13. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.
Le Meur G; Lebranchu P; Billaud F; Adjali O; Schmitt S; Bézieau S; Péréon Y; Valabregue R; Ivan C; Darmon C; Moullier P; Rolling F; Weber M
Mol Ther; 2018 Jan; 26(1):256-268. PubMed ID: 29033008
[TBL] [Abstract][Full Text] [Related]
14. Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.
Daich Varela M; Cabral de Guimaraes TA; Georgiou M; Michaelides M
Br J Ophthalmol; 2022 Apr; 106(4):445-451. PubMed ID: 33712480
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
Rakoczy EP; Narfström K
Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review.
Sallum JMF; Kaur VP; Shaikh J; Banhazi J; Spera C; Aouadj C; Viriato D; Fischer MD
Adv Ther; 2022 Mar; 39(3):1179-1198. PubMed ID: 35098484
[TBL] [Abstract][Full Text] [Related]
17. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
[TBL] [Abstract][Full Text] [Related]
18. Cone-rod dystrophy caused by a novel homozygous RPE65 mutation in Leber congenital amaurosis.
Jakobsson C; Othman IS; Munier FL; Schorderet DF; Abouzeid H
Klin Monbl Augenheilkd; 2014 Apr; 231(4):405-10. PubMed ID: 24771178
[TBL] [Abstract][Full Text] [Related]
19. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
[TBL] [Abstract][Full Text] [Related]
20. Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.
Chung DC; Traboulsi EI
J AAPOS; 2009 Dec; 13(6):587-92. PubMed ID: 20006823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]